Bibliographie (2530)
2021 guidelines for management of venous thromboembolism in Latin America.
jeudi, 12 août 2021 11:09 Écrit par Zouhair SouissiASH, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, and SVH 2021 guidelines for management of venous thromboembolism in Latin America – Blood Advances
The post 2021 guidelines for management of venous thromboembolism in Latin America. appeared first on Links Medicus.
WHO’s Solidarity clinical trial enters a new phase with three new candidate drugs.
jeudi, 12 août 2021 11:09 Écrit par Zouhair SouissiWHO’s Solidarity clinical trial enters a new phase with three new candidate drugs – World Health Organization Commentary: WHO-led Trial Will Test Malaria and Cancer Medicines Against COVID-19 – Health Policy Watch Related: A giant trial of COVID-19 treatments organized by the WHO is restarting. Here are the drugs it’s betting on. WHO Solidarity trial […]
The post WHO’s Solidarity clinical trial enters a new phase with three new candidate drugs. appeared first on Links Medicus.
Clinical features of vaccine-induced immune thrombocytopenia and thrombosis.
jeudi, 12 août 2021 11:09 Écrit par Zouhair SouissiClinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis – New England Journal of Medicine Commentary: Largest Study of VITT After COVID-19 Vaccination Digs Into Lab, Clinical Features – TCTMD Related: Review: Clinical characteristics and pharmacological management of COVID-19 vaccine–induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis. NICE COVID-19 rapid guideline: vaccine-induced immune thrombocytopenia and […]
The post Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. appeared first on Links Medicus.
RCT: Triaging acute pulmonary embolism for home treatment by Hestia vs. simplified PESI criteria – the tools were similarly effective, and more than a third of patients were treated at home with a low incidence of complications.
mercredi, 11 août 2021 11:18 Écrit par Zouhair SouissiTriaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial – European Heart Journal Commentary on Twitter Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial #EHJ #PE #PERThttps://t.co/gszusChSyU pic.twitter.com/NOyKYsVQHo — EHJ Editor-in-Chief (@ehj_ed) August 10, 2021
The post RCT: Triaging acute pulmonary embolism for home treatment by Hestia vs. simplified PESI criteria – the tools were similarly effective, and more than a third of patients were treated at home with a low incidence of complications. appeared first on Links Medicus.
CDC Report: COVID-19 morbidity and mortality far exceed the potential risks of rare side effects caused by vaccines.
mercredi, 11 août 2021 11:18 Écrit par Zouhair SouissiUse of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021 – CDC Morbidity and Mortality Weekly Report
The post CDC Report: COVID-19 morbidity and mortality far exceed the potential risks of rare side effects caused by vaccines. appeared first on Links Medicus.
Review: Clinical characteristics and pharmacological management of COVID-19 vaccine–induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis.
mercredi, 11 août 2021 11:18 Écrit par Zouhair SouissiClinical Characteristics and Pharmacological Management of COVID-19 Vaccine–Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review – JAMA Cardiology Related: NICE COVID-19 rapid guideline: vaccine-induced immune thrombocytopenia and thrombosis. Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know. Very rare cases of thrombosis with thrombocytopenia syndrome (TTS) after AstraZeneca vaccine: a […]
The post Review: Clinical characteristics and pharmacological management of COVID-19 vaccine–induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis. appeared first on Links Medicus.
M-A: Asymptomatic SARS-CoV-2 infection – “we estimate that the percentage of infections that never developed clinical symptoms, and thus were truly asymptomatic, was 35.1%”.
mercredi, 11 août 2021 11:18 Écrit par Zouhair SouissiAsymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis – Proceedings of the National Academy of Sciences Commentary on Twitter The best comprehensive review of the asymptomatic status with Covid, >350 studies, just out @PNASNews https://t.co/xyfgyGXANLOverall: true, never had symptoms 35%; children 47%@Pratha_Sah @Alison_Galvani @MeaganCFitz @YaleSPH & colleagues(wonder what the rate is w/ Delta) pic.twitter.com/9W6wbvQno6 […]
The post M-A: Asymptomatic SARS-CoV-2 infection – “we estimate that the percentage of infections that never developed clinical symptoms, and thus were truly asymptomatic, was 35.1%”. appeared first on Links Medicus.
M-A: More than 50 long-term effects of COVID-19.
mercredi, 11 août 2021 11:18 Écrit par Zouhair SouissiMore than 50 long-term effects of COVID-19: a systematic review and meta-analysis – Scientific Reports Related: Illness duration and symptom profile in symptomatic school-aged children tested for SARS-CoV-2 – “Only 25 (1.8%) of 1379 children experienced symptoms for at least 56 days.” Cohort study: Risk factors for long covid in previously hospitalized children. Viewpoint: The […]
The post M-A: More than 50 long-term effects of COVID-19. appeared first on Links Medicus.
PRINCIPLE RCT: Inhaled budesonide improves time to recovery from COVID-19 in people at high risk of complications in the community.
mercredi, 11 août 2021 11:18 Écrit par Zouhair SouissiInhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial – The Lancet Invited Commentary: The use of inhaled corticosteroids in early-stage COVID-19
The post PRINCIPLE RCT: Inhaled budesonide improves time to recovery from COVID-19 in people at high risk of complications in the community. appeared first on Links Medicus.
Study ties COVID vaccines to lower transmission rates.
mardi, 10 août 2021 15:09 Écrit par Zouhair SouissiStudy ties COVID vaccines to lower transmission rates – CIDRAP Original study: Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021 – Eurosurveillance
The post Study ties COVID vaccines to lower transmission rates. appeared first on Links Medicus.
![[Preprint] Phase 1/2 RCT: A booster dose is immunogenic and will be needed for older adults who have completed two doses vaccination with CoronaVac.](/media/k2/items/cache/32e0741e68cabc7552333046597de1b4_XS.jpg)